throbber
Select Injectable Insulin Drugs Approved by the FDA in the U.S. [1]
`
`Drug
`
`Active Ingredient
`
`Company
`
`U.S. Launch Date [2]
`
`Method of Administration
`Vial
`Pen
`
`Strength [3]
`
`Fast-Acting [4]
`Admelog SoloSTAR
`Admelog Vial
`Apidra Vial
`Apidra OptiClik
`Apidra SoloSTAR
`Humalog Reusable Pen
`Humalog Vial
`Humalog Pen
`Humalog KwikPen
`Humalog Jr. KwikPen
`Humulin R Pen
`Humulin R Vial
`Humulin R KwikPen
`Novolog Vial
`Novolog Pen
`Novolog FlexPen
`
`Insulin Lispro
`Insulin Lispro
`Insulin Glulisine
`Insulin Glulisine
`Insulin Glulisine
`Insulin Lispro
`Insulin Lispro
`Insulin Lispro
`Insulin Lispro
`Insulin Lispro
`Insulin Human
`Insulin Human
`Insulin Human
`Insulin Aspart
`Insulin Aspart
`Insulin Aspart
`
`Intermediate-Acting [5]
`Humalog Pen Mix 75/25
`Humalog Mix 75/25 Vial
`Humalog Pen Mix 50/50
`Humalog Mix 50/50 Vial
`Humalog KwikPen 50/50
`Humalog KwikPen 75/25
`Novolog FlexPen Mix 70/30
`Novolog Mix 70/30 Vial
`
`Insulin Lispro
`Insulin Lispro
`Insulin Lispro
`Insulin Lispro
`Insulin Lispro
`Insulin Lispro
`Insulin Aspart
`Insulin Aspart
`
`Sanofi Aventis
`Sanofi Aventis
`Sanofi Aventis
`Sanofi Aventis
`Sanofi Aventis
`Eli Lilly
`Eli Lilly
`Eli Lilly
`Eli Lilly
`Eli Lilly
`Eli Lilly
`Eli Lilly
`Eli Lilly
`Novo Nordisk
`Novo Nordisk
`Novo Nordisk
`
`Eli Lilly
`Eli Lilly
`Eli Lilly
`Eli Lilly
`Eli Lilly
`Eli Lilly
`Novo Nordisk
`Novo Nordisk
`
`March 2018
`March 2018
`January 2006
`February 2006
`April 2009
`August 1996
`August 1996
`December 1998
`January 2008
`September 2017
`July 1983
`July 1983
`March 2016
`August 2001
`September 2001
`February 2003
`
`February 2000
`December 2000
`February 2006
`November 2006
`January 2008
`January 2008
`September 2002
`February 2003
`
`X
`X
`
`X
`
`X
`
`X
`
`X
`
`X
`
`X
`
`X
`
`X
`X
`X
`
`X
`X
`X
`X
`
`X
`
`X
`X
`
`X
`
`X
`
`X
`X
`X
`
`100U/ML
`100U/ML
`100U/ML
`100U/ML
`100U/ML
`100U/ML
`100U/ML
`300U/3ML
`1 00U/ML and 200U/ML
`100U/ML
`100U/ML
`1 00U/ML and 500U/ML
`500U/ML
`100U/ML
`300U/3ML
`100U/ML
`
`100U/ML
`100U/ML
`100U/ML
`100U/ML
`100U/ML
`100U/ML
`100U/ML
`100U/ML
`
`Sanofi Exhibit 2186.001
`Mylan v. Sanofi
`IPR2018-01675
`
`

`

`Select Injectable Insulin Drugs Approved by the FDA in the U.S. [1]
`
`Drug
`
`Active Ingredient
`
`Company
`
`U.S. Launch Date [2]
`
`Method of Administration
`Vial
`Pen
`
`Strength [3]
`
`Long-Acting
`Basaglar KwikPen
`Humulin U Vial [6]
`Lantus Vial
`Lantus OptiClik
`Lantus SoloST AR
`Levemir FlexPen
`Levemir Vial
`Levemir FlexTouch
`Toujeo SoloSTAR
`Toujeo Max SoloSTAR
`Tresiba FlexTouch
`
`Insulin Glargine
`Insulin Human
`Insulin Glargine
`Insulin Glargine
`Insulin Glargine
`Insulin Detemir
`Insulin Detemir
`Insulin Detemir
`Insulin Glargine
`Insulin Glargine
`Insulin Degludec
`
`Eli Lilly
`Eli Lilly
`Sanofi Aventis
`Sanofi Aventis
`Sanofi Aventis
`Novo Nordisk
`Novo Nordisk
`Novo Nordisk
`Sanofi Aventis
`Sanofi Aventis
`Novo Nordisk
`
`December 2016
`July 1987
`April 2001
`January 2005
`July 2007
`February 2006
`February 2006
`May 2014
`March 2015
`April 2018
`November 2015
`
`X
`X
`
`X
`
`X
`
`X
`X
`X
`
`X
`X
`X
`X
`
`100U/ML
`100U/ML
`100U/ML
`100U/ML
`100U/ML
`100U/ML
`100U/ML
`100U/ML
`300U/ML
`300U/ML
`1 00U/ML and 200U/ML
`
`Source: IMS Health; U.S. Food & Drug Administration
`Note:
`[1] Drugs included are either sold by Sanofi, part of the Humalog Franchise, Humulin U Vial, Novolog Mix 70/30 Vial, had over $350,000,000 in sales in 2018, or had an
`accompanying administration with over $350,000,000 in sales in 2018.
`[2] Launch date is defined as the first month of IMS data with non-zero sales or prescriptions. For drugs launched prior to January 2001, launch date is defined as the
`date listed in the Product variable in the IMS data.
`[3] Strength is measured in insulin units per milliliter.
`[4] other fast-acting drugs in the IMS data are Fiasp FlexTouch, Fiasp Vial, Human Insulin R Vial, Humulin BR Vial, Novolin R lnnolet Pen, Novolin R Pen, Novolin R
`Prefilled Pen, Novolin R Vial, Relion R Vial, Velosulin Human BR Vial, and Velosulin RONA BR Vial.
`[5] other intermediate-acting drugs in the IMS data are Human Insulin 70/30 Pen, Human Insulin 70/30 Vial, Human Insulin N Pen, Human Insulin N Vial, Humulin 50/50
`Vial, Humulin 70/30 KwikPen, Humulin 70/30 Pen, Humulin 70/30 Pen (Unspecified), Humulin 70/30 Vial, Humulin L Vial, Humulin N KwikPen, Humulin N Pen,
`Humulin N Pen (Unspecified), Humulin N Vial, Mixtard Human 70/30 Vial, Novolog Mix 70/30 Pen, Novolin 70/30 FlexPen, Novolin 70/30 lnnolet Pen, Novolin 70/30
`Pen, Novolin 70/30 Prefilled Pen, Novolin 70/30 Vial, Novolin L Vial, Novolin N lnnolet Pen, Novolin N Pen, Novolin N Prefilled Pen, Novolin N Vial, Relion 70/30 Vial,
`Relion N Vial, Relion Novolin 70/30 Vial, and Relion Novolin N Vial.
`[6] Humulin U Vial was discontinued in 2005.
`
`Sanofi Exhibit 2186.002
`Mylan v. Sanofi
`IPR2018-01675
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket